In order to prevent spam,
this email address cannot be copied.
Researcher Profile - Gianluigi Forloni Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Community: Researcher Profiles
Researcher Profile

RESEARCHER INFORMATION
First Name:Gianluigi
Last Name:Forloni
Title:PhD
Affiliation:Istituto di Ricerche Framacologiche "Mario Negri"
Department:Neuroscience
Street Address 1:Via G. La Masa 19
City:Milano
Zip/Postal Code:20156
Country/Territory:Italy
Phone:39 0239014462
Fax:39 0239001619
Email Address: 
Disclosure:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 21 February 2008]
View all comments by Gianluigi Forloni
Clinical Interests:
Aging Process, Prion Diseases, Alzheimer Disease
Research Focus:
A-beta PP/A-beta, Apoptosis/Cell cycle, Proteomics, Genetics, Animal Models, Neurobiology, Drug screening
Work Sector(s):
Research institute
Web Sites:
Professional: www.marionegri.it
Top Papers
Colombo A, Repici M, Pesaresi M, Santambrogio S, Forloni G, Borsello T. The TAT-JNK inhibitor peptide interferes with beta amyloid protein stability.
Cell Death Differ. 2007 Oct;14(10):1845-8. Epub 2007 Jul 20.
PMID: 17641679

Fioriti L, Angeretti N, Colombo L, De Luigi A, Colombo A, Manzoni C, Morbin M, Tagliavini F, Salmona M, Chiesa R, Forloni G. Neurotoxic and gliotrophic activity of a synthetic peptide homologous to Gerstmann-Sträussler-Scheinker disease amyloid protein.
J Neurosci. 2007 Feb 14;27(7):1576-83.
PMID: 17301166

Forloni G, Terreni L, Bertani I, Fogliarino S, Invernizzi R, Assini A, Ribizzi G, Negro A, Calabrese E, Volonté MA, Mariani C, Franceschi M, Tabaton M, Bertoli A.
Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms.
Neurobiol Aging. 2002 Sep-Oct;23(5):957-76. Review.
PMID: 12392798

Forloni G, Iussich S, Awan T, Colombo L, Angeretti N, Girola L, Bertani I, Poli G, Caramelli M, Grazia Bruzzone M, Farina L, Limido L, Rossi G, Giaccone G, Ironside JW, Bugiani O, Salmona M, Tagliavini F.
Tetracyclines affect prion infectivity.
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10849-54.
PMID: 12149459

Forloni G, Colombo L, Girola L, Tagliavini F, Salmona M.
Anti-amyloidogenic activity of tetracyclines: studies in vitro.
FEBS Lett. 2001 Jan 5;487(3):404-7.
PMID: 11163366

Galbete JL, Martin TR, Peressini E, Modena P, Bianchi R, Forloni G. Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway.
Biochem J. 2000 Jun 1;348 Pt 2:307-13.
PMID: 10816423

Forloni G, Bertani I, Calella AM, Thaler F, Invernizzi R.
Alpha-synuclein and Parkinson's disease: selective neurodegenerative effect of alpha-synuclein fragment on dopaminergic neurons in vitro and in vivo.
Ann Neurol. 2000 May;47(5):632-40.
PMID: 10805334

Tagliavini F, McArthur RA, Canciani B, Giaccone G, Porro M, Bugiani M, Lievens PM, Bugiani O, Peri E, Dall'Ara P, Rocchi M, Poli G, Forloni G, Bandiera T, Varasi M, Suarato A, Cassutti P, Cervini MA, Lansen J, Salmona M, Post C.
Effectiveness of anthracycline against experimental prion disease in Syrian hamsters.
Science. 1997 May 16;276(5315):1119-22.
PMID: 9148807

Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, Bugiani O, Tagliavini F.
Neurotoxicity of a prion protein fragment.
Nature. 1993 Apr 8;362(6420):543-6.
PMID: 8464494

Bendotti C, Forloni GL, Morgan RA, O'Hara BF, Oster-Granite ML, Reeves RH, Gearhart JD, Coyle JT.

Neuroanatomical localization and quantification of amyloid precursor protein mRNA by in situ hybridization in the brains of normal, aneuploid, and lesioned mice.
Proc Natl Acad Sci U S A. 1988 May;85(10):3628-32
PMID: 2897124
What is the greatest void to date in our knowledge of Alzheimer's Disease?
The relationship between beta amyloid deposition and neurofibrilalry tangles in AD and more in general the relationship between protein misfolding and neuronal degeneration
What are the top three papers (not yours) you have read recently?
Meyer-Luehmann M, Spires-Jones TL, Prada C, Garcia-Alloza M, de Calignon A, Rozkalne A, Koenigsknecht-Talboo J, Holtzman DM, Bacskai BJ, Hyman BT.
Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease.
Nature. 2008 Feb 7;451(7179):720-4.
PMID: 18256671

Sundelöf J, Giedraitis V, Irizarry MC, Sundström J, Ingelsson E, Rönnemaa E, Arnlöv J, Gunnarsson MD, Hyman BT, Basun H, Ingelsson M, Lannfelt L, Kilander L.
Plasma {beta} Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men: A Prospective, Population-Based Cohort Study.
Arch Neurol. 2008 Feb;65(2):256-63.
PMID: 18268197

Carroll JC, Pike CJ.
Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice.
Endocrinology. 2008 Feb 14; [Epub ahead of print]
PMID: 18276750
If resources were not limited, what research projects would you pursue?
The longitudinal analysis of CSF by proteomic technique and numerous other parametrs in a large aged population with a follow up of several years to analyze the conversion in MCI and AD
What is your leading hypothesis?
The combination of several causes induce the synaptic loss in AD, the dissection of the single contribution and the role of amyloid
What piece of missing evidence would help prove it?
A good animal model

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad